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Q1 Q2The nature of the conserved basic amino acid
sequences found among 437 heparin binding
proteins determined by network analysis†
Timothy R. Rudd,*ab Mark D. Prestona and Edwin A. Yatesb
In multicellular organisms, a large number of proteins interact with the polyanionic polysaccharides
heparan sulphate (HS) and heparin. These interactions are usually assumed to be dominated by charge–
charge interactions between the anionic carboxylate and/or sulfate groups of the polysaccharide and
cationic amino acids of the protein. A major question is whether there exist conserved amino acid
sequences for HS/heparin binding among these diverse proteins. Potentially conserved HS/heparin bind-
ing sequences were sought amongst 437 HS/heparin binding proteins. Amino acid sequences were
extracted and compared using a Levenshtein distance metric. The resultant similarity matrices were
visualised as graphs, enabling extraction of strongly conserved sequences from highly variable primary
sequences while excluding short, core regions. This approach did not reveal extensive, conserved HS/
heparin binding sequences, rather a number of shorter, more widely spaced sequences that may work in
unison to form heparin-binding sites on protein surfaces, arguing for convergent evolution. Thus, it is
the three-dimensional arrangement of these conserved motifs on the protein surface, rather than the
primary sequence per se, which are the evolutionary elements.
1. Introduction
Heparan sulfate (HS) and heparin are closely related linear
polyanionic carbohydrates (Scheme 1), which are members of a
class of polysaccharide known as glycosaminoglycans (GAGs).1
Heparan sulfate is a ubiquitous element of mammalian cells
and plays an important physiological role, including receptor–
ligand clustering and signalling, cell-to-cell cross talk and
adhesion, chemokine presentation, storage, cell adhesion and
extracellular matrix (ECM) formation. Heparan sulfate is found
on the surface of cells as a part of proteoglycans (HSPG), for
example, syndecan and glypican,2 as well as being an integral
component of the ECM, where HS is attached to proteoglycans
such as agrin and perlecan.3 Heparan sulfate has also been
found in the cell nucleus,4,5 although the functional signifi-
cance of this remains unclear.
Owing to its abundance, relatively low cost and overall
structural similarity, heparin is often used as an experimental
proxy for HS. Heparin is readily available as a widely used
pharmaceutical anticoagulant which originates in mast cells,
where the polysaccharides are stored in intracellular granules
as serglycin proteoglycans. Mast cells can be stimulated to eject
their granules, a process termed degranulation, through phy-
sical/chemical damage or through interaction with IgE, cyto-
kines and others agents.
Heparin is composed of the same disaccharide units,
although in diﬀerent proportions, and both HS and heparin
share a common biosynthetic pathway.6 The polysaccharides
comprise alternating disaccharides of an uronic acid linked
1
5
10
15
20
25
30
35
40
45
50
55
1
5
10
15
20
25
30
35
40
45
50
55
Cite this:DOI: 10.1039/c6mb00857g
Scheme 1 General repeating disaccharide structure of HS and heparin
polysaccharides; [(4) L-IdoA a(1-4) D-GlcN a(1)], where R1 = H or SO3,
R2 = H/COCH3 or SO3
 and R3 = H or SO3
. The a-L-IdoA residue can be
replaced by its C-5 epimer, b-D-GlcA. HS has lower overall sulfation than
heparin, possesses a more distinct domain structure and a higher propor-
tion of GlcA residues.
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1-4 to a-D-glucosamine. The uronic acid can be present as b-D-
glucuronic acid, or its C-5 epimer, a-L-iduronic acid, both of
which can beO-sulfated at position 2. The glucosamine can beO-
sulfated at positions 3 and 6, as well as N-acetylated, N-sulfated,
or unsubstituted at position 2. The major repeating disaccharide
unit of heparin is shown in Scheme 1. The large number of
possible enzymatic modifications involved in the biosynthesis
together with the non-template-driven nature of their biosynth-
esis, results in highly heterogeneous polysaccharides.7,8
The principal diﬀerence between HS and heparin resides in
the organisation and content of their domain structures. The
majority of the HS chain is composed of [(4) D-GlcA a(1-4) D-
GlcNAc a(1)], disaccharide repeats containing glucuronic acid
and N-acetyl glucosamine, exhibiting little or no sulfation. Inter-
spersed between low sulfation domains are sequences with higher
degrees of sulfation. It is in these high sulfation regions, where the
majority of protein interactions are thought to occur,9,10 that have a
structuremore closely resembling that of heparin. Heparin consists
of around 80% of the trisulfated disaccharide, [(4) L-IdoA2-O-
sulfate a(1-4) D-GlcN-sulfate,6-O-sulfate a(1)]. Heparin is
composed of around eighty percent of this trisulfated disaccharide,
making it more homogenous than HS.7
It is often stated that heparan sulfate and heparin interact
with numerous, key proteins primarily via the high sulfation
regions in HS/heparin. This statement is perhaps tautological,
since almost all experimental investigations have involved the
selection of proteins bound to HS/heparin via elution from a
heparin column using salt that inherently selects for high
charge interactions.11 Ori et al.12 compiled a list of 435, non-
redundant, human HS/heparin binding proteins (HEPbps) in
the HS/heparin interactome, which include members of impor-
tant protein families, such as growth factors, cytokines and
morphogens. Heparan sulfate is a molecule that, in some
manner, choreographs signalling pathways thereby allowing
information to cross the cell membrane.11,13 Heparin binding
proteins play a key role in controlling development, for exam-
ple, via the Wnt, Hedgehog, transforming growth factor-beta
and fibroblast growth factor (FGF) pathways.14 Furthermore,
HS has been implicated in diseases such as Alzheimer’s,15
cancer16 and sexually transmitted infections.17 Recently, Nunes
et al.18 performed a study to examine the role of HEPbps in
pancreatic diseases, concluding that a concerted network of
highly connected HEPbps was important for distinguishing
between normal and diseased pancreatic tissue. Chen et al.19
showed that the interaction between the cell surface HSPGs of
two-breast cancer cell lines and their innate complement of
HEPbps is a key component of tumourigenicity. Inhibition of
the innate HEPbps of breast cancer cell lines by the addition of
extraneous heparin perturbed the PI3K/Akt and Raf/MEK/ERK
signalling pathways.
In evolutionary terms, HEPbps are thought to originate at the
dawn of multicellular life, via colonies of communicating unicel-
lular organisms.Monosiga brevicollis is one such organism and it is
known to contain the biosynthetic machinery necessary to produce
heparin/HS.12M. brevicollis also possesses receptor tyrosine kinases
(RTK),20 and the HEPbps FGF family are ligands for RTKs in
metazoans. Recently, Bertrand et al. found orthologous genes to
the FGFs in M. Brevicollis and proposed that FGFs and their
receptors originated in a eumetazoan ancestor.21 Finally, three
GAG lyases have also been predicted in the proteome of the
organism.22 These observations indicate that what is often consid-
ered a relatively simple organism possesses the full apparatus of a
HSPG-mediated cell-signalling system. Furthermore, M. Brevicollis
possesses lyases capable of causing GAGs to be shed into the
environment and is, in principle, therefore, able to interact with its
neighbours via protein and glycan communication. Such findings
support the idea that HEPbps are crucial for, andmay be a defining
characteristic of, multicellular animal life.
Basic amino acids in HEPbps are postulated as being key to
interactions with HS/heparin. Linhardt et al. published a num-
ber of studies investigating the heparin binding properties of the
three basic amino acids,23–25 arginine, lysine and histidine. They
concluded that the affinity between heparin and arginine is
higher than that between heparin and lysine. Histidine exhibits
low affinity and only at pH values at which it is protonated
(below its pKa of ca. 6.5). The frequency, location and structure of
basic amino acids in HEPbps are consequently likely to be
important determinants of their binding properties.
Heparin binding sequences (HBSs) are amino acid
sequences found in HEPbps that have been shown, or are
predicted to be, the domains that bind to HS/heparin. Cardin
and Weintraub26 reported two sequences, XBBBXXBX and
XBBXBX in the heparin binding proteins: apo B; apo E; vitro-
nectin; and platelet factor 4 (where B and X signify basic and
hydropathic amino acids, respectively). These sequences were
then used to predict HBSs in other proteins and a similar
approach was used to propose the von Willebrand factor HBS –
XBBBXXBBBXXBBX.27 Subsequently, Hileman et al. proposed
the heparin-binding consensus sequence TXXBXXTBXXXTBB
(T denotes a turn), combining secondary structure information
and conserved sequence information. This sequence was
proposed using the crystallographic/NMR structural data for
FGF-1 and -2 and transforming growth factor (TGF). A recent
theory proposed by Torrents et al., defines a minimal sequence,
termed the ‘‘CPC clip motif’’ (C – cationic and P – polar
residues), with this sequence working analogously to a staple;
small points of contact pinning the polysaccharide to the
protein.28 Even in combination, however, these studies have
only surveyed a very small fraction of HEPbps, which may be
too small for global features to become apparent. By examining
all HEPbp sequences, it was thought that more general, under-
lying similarities may emerge.
The aim of this present study is to identify HBSs within all
currently collated HEPbps. To do this, a sequence similarity
metric paired with graph analysis29 will be employed to inves-
tigate conserved sequences within HEPbps that contain basic
amino acids. The similarity between amino acid sequences was
determined here using the Levenshtein distance (DL).
30 Levensh-
tein distance is also called the edit distance and is defined as
the minimum number of single letter elementary operations
(insertions, deletions and replacements) required to convert
one character string into another. This measure is used widely
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to compare strings of information, including in applications to
protein interactions with small ligands31 within the field of
protein interactions, which is reviewed in ref. 32. In the present
work, a similarity matrix was created from the DL’s to compare
the basic sequences. The similarity matrices were transformed
into a graph to visualise and analyse these data and this
analysis allowed strongly conserved sequences to be extracted
from among the highly variable 437 HEPbps, while excluding
short, core regions. It is possible that a number of these
sequences work in unison to form heparin-binding domains
on protein surfaces. The results are consistent with convergent
evolution, in which the three-dimensional arrangement of
amino acids on the protein surface is the evolutionary element,
rather than the primary sequence. Furthermore, when the
human proteome was searched for the sequences found in
the relatively small population of verified HEPbps, it became
clear that many proteins may be able to interact with heparin/
HS. Indeed, this may be an innate property of extracellular
proteins. This calls into question the possible control mecha-
nism behind protein:heparin/HS interactions; instead of con-
sidering a protein binding to a defined carbohydrate sequence,
a more holistic concept should be considered.
2. Material and methods
2.1 Determination of heparin binding sequence (HBS)
similarity matrices and the subsequent formation of networks
Four hundred and thirty seven HEPbp amino acid sequences
were retrieved through UNIPROT.33 The original HEPbps list12
contained 435 proteins, from which FBS1 (Fibrosin-1, consid-
ered obsolete and removed from UNIPROT, accession number
(a/no.) P62706) and IAPP (Islet Amyloid Polypeptide, a/no.
P10997) were excluded. FGF11, 13, 19 and 21 (a/no. Q92914,
Q92913, O95750 and Q9NSA1, respectively) were added, provid-
ing a final list containing 437 proteins.
A search was made for seven amino acid sets within the
HEPbps. The sets searched for were {B,X}, {B,X,A}, {B,X,P},
{B,X,S}, {B,X,P,A}, {B,X,P,S} and {B,X,A,S}, composed of the five
diﬀerent types of amino acid: basic (B); hydrophobic (X); polar
(P); special (S); and acidic (A) (see ESI,† Table S1 for more
details). In the text, these set names are abbreviated to BX, BXA,
BXP, BXS, BXPA, BXPS and BXAS. These sets are neither
exclusive nor are they exhaustive. Each HBS was read serially
from the N- to C-terminus to identify amino acid sequences.
Sequences had a minimum length of 3 amino acids.
For the group of amino acid sequences identified from each
amino acid set, a similarity matrix (Scheme 2A) was calculated
using a normalised Levenshtein distance. The Levenshtein dis-
tance was defined as the minimum number of elementary
character operations (insert, delete or replace a single letter)
required to transform one sequence into another:
DL(a,b) := min(i(a,b) + d(a,b) + r(a,b)) (1)
where DL(a,b) is the Levenshtein distance for the conversion of a
to b. The terms i, d and r stand for insert, delete and replace,
respectively. The normalised Levenshtein distance metric for the
conversion of a into b was defined as:
DLm(a,b) := 1  (DL(a,b)/max length (a,b)) (2)
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Scheme 2 (A) Similarity matrix of the BX (basic and hydrophobic) amino
acid-containing amino acid sequences, found in the FGF family. It is
diﬃcult to extract information from the data contained within the similarity
matrix. The relationships between the proteins and basic amino acid
containing sequences becomes clearer when the matrix is converted into
a network, in the form of a graph. (B) Graph representations of the basic
amino acid containing sequences found in the FGF family. The similarity
cut-oﬀ (95% confidence interval of the Levenshtein matrix values) for the
network was 0.57. The colour and shape of the vertices indicate which
member of the FGF subfamily the sequence originated from, provided as a
legend on the figure. The thickness of each edge is proportional to the
similarity of the HBSs linked; the thicker the edge, the more similar are the
vertices.
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where max length (a,b) is the length of the longest string, either
a or b. Identical HBPs have a Levenshtein distance metric of 1,
while entirely dissimilar sequences will have 0 Levenshtein
distance. A 0.7 normalised Levenshtein distance cut-oﬀ was
applied to the similarity matrix to remove dissimilar sequences.
The similarity matrices were visualised and further analysed in
graph form (Schemes 2B and 3). Each node/vertex in the graph
represents two properties: a sequence and the protein in which it is
found. The edges of the graph are weighted by the similarity matrix
(above the cut-oﬀ) or non-existent (below the cut-oﬀ). In the
subsequent analysis a sequence within a protein is only compared
with sequences from other proteins and not to sequences within
the same protein. The graph layouts were determined using
Fruchterman-Reingold and force-directed algorithms.34
If we consider only one component (sequence or protein) of
vertex identity this reduces the number of vertices and there-
fore the complexity of the graphs. When there exist multiple
edges between two vertices these are collapsed into one single
edge with new weight defined as the sum of the weights of the
original edges. A number of parameters are used to describe the
resultant vertices and graphs, and are defined as:
(Vertex) degree. This is the number of edges incident at a
vertex. The higher the value, then the more similar the
sequence represented by the vertex is to the other sequences
present in the network.
(Vertex) closeness. This measures the number of steps
required to reach every other vertex from a given vertex. There-
fore, an important vertex is close to, and can communicate
rapidly with, the other vertices in a network. The closeness of a
vertex is defined as the reciprocal of the sum of the distances
from the vertex of interest to all of the others in the graph.
Network density. This is the measure of the total possible
number of edges verses the actual number of edges in a graph.
A network density of 1 equates to the number of possible edges
equalling the number of actual edges. The higher the value the
more similar the sequences represented by the network are to
each other.
Clustering coeﬃcient. This is the mean probability that two
vertices adjacent to a vertex are themselves adjacent. This
quantity is also termed transitivity and is calculated by deter-
mining the number of triangles in the entire network and
dividing it by the total number of possible/theoretical triangles.
Modularity. This is a measure of the structure of a graph. It
is a measure of how a network can be subdivided into modules
(i.e., groups, clusters or communities). A graph with high mod-
ularity has dense connections between the nodes within mod-
ules but sparse connections between nodes in diﬀerent modules,
i.e., high intra-group degree and low inter-group degree.
Betweenness centrality. ‘‘An important node will lie on a high
proportion of paths between other nodes in the network.’’ This
centrality provides a measure of the control a vertex exerts over
other vertices in the network.
Bonacich’s centrality (also called the eigenvector centrality).
‘‘An important node is connected to important neighbours.’’ This
centrality is an evolution of the degree centrality, the degree
centrality awards points for connections, not all vertices are
equal, however. The eigenvector centrality identifies vertices
that are connected to other important vertices.
Further information regarding graphs and their analysis can
be found in ref. 29.
The resultant graphs were further refined by only consider-
ing the core of the graph; the highly connected heart of the
network, which was defined using the closeness centrality.
The graphs were further collapsed by translating the devol-
ving amino acids found in the basic amino acid containing
sequences into their groups: B, X, P, S or A (see ESI,† Table S1).
For example, the sequence LLR is converted to XXB. The multi-
ple parallel edges were again collapsed into one single edge with
weight equal to the sum of the constituent original edges.
2.2 Computation
The analyses were performed using R 3.1.2 ‘‘Pumpkin Helmet’’35
running on a MacBook Pro (2.66 GHz Intel Core i7, 8 Gb RAM).
Levenshtein distances were determined using the Levenshtein-
Dist function from the RecordLinkage package.36 Networks were
created using the igraph package34 and similarity matrices were
plotted using the lattice package.37 Parallel processing in R was
implemented using the foreach38 and doParallel39 packages.
3. Results
3.1 Network description
Heparin binding protein amino acid sequences were decom-
posed into sequences comprising only amino acids contained
within given amino acids subsets. Seven diﬀerent amino acid
subsets were considered, the simplest being amino acid
sequences containing basic and hydropathic amino acids
({B,X} sequences). The other basic amino acid containing
sequences considered were {B,X,A}, {B,X,P}, {B,X,S}, {B,X,P,A},
{B,X,P,S} and {B,X,A,S} sequences. These basic amino acid
containing sequences were then compared using graphs
derived from Levenshtein distance metric similarity matrices.
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Scheme 3 Schematic of a HEPbp HBS graph. The vertices represent a
basic amino acid sequence from a heparin binding protein. The vertex
contains both pieces of information. The connections between vertices is
the similarity of the amino acid sequences. The width of the edges is
proportional to the weight of the edge. In this analysis amino acid
sequences arising from the same protein are not considered, i.e., there is
no edge between the vertices belonging to protein 1 in the above
schematic.
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A graph is composed of edges and vertices, a vertex represents a
basic amino acid sequence and the protein from which that
sequence originates. Vertices are connected by edges and, if two
vertices are connected by an edge, this signifies that the
similarity criteria was met for those two vertices and then the
weight of the edge connecting them is the similarity value. The
purpose of this analysis was to identify conserved basic amino
acid sequences within the HEPbps; the hypothesis being that
these sequences may be characteristic for HEPbps and form the
heparin binding regions of the proteins. Two parameters were
used to guarantee that only conserved sequences were consid-
ered. The first was an imposed similarity cut-oﬀ, i.e., two
vertices were not considered to be connected if the similarity
between the vertices was below the similarity cut-oﬀ. Second,
the core of the graph, the highly connected heart of the
network, was selected by using the closeness centrality.
3.2 Similarity cut-oﬀ
For this study the similarity cut-oﬀ for the conserved basic
amino acid sequence graphs was set at 0.7. The eﬀect of varying
the similarity cut-oﬀ can be observed in ESI,† Table S2. As
expected, by increasing the similarity cut-oﬀ for the networks
the number of vertices, unique sequences and the number of
edges decreased. This is also true for the graphs network
density and the average degree of the vertices within the
graphs, while the transitivity of the graphs increased with the
raising of the similarity cut-oﬀ, i.e., there is an increased
probability that adjacent vertices of a vertex are connected.
3.3 Network core selection
Unlike the analysis of a family of highly related proteins, such
as the FGF family shown earlier (Scheme 2), the networks
produced from the 437 HEPbps contain many isolated vertices,
which are detached from the core of the graph. These vertices
belong to sequences that are not highly conserved. When
community analysis, using a walktrap algorithm, was per-
formed on these networks many communities were found, for
example, the BX graph contained 566 communities, the BXP
graph 1311 communities and the BXPS graph 821 communities
(Table 1), with most of these communities having a low number
of members and a low average degree. The walktrap algorithm
used to detect communities in a network is based on a random
walk; short random walks tend to stay in the same community.
The number of steps used by the algorithm can be defined. In
this case seven steps were used, minimising the number of
communities found while maximising the modularity of the
network.
To isolate the highly conserved cores of the networks, the
closeness measure of vertex centrality was used. This measure
finds vertices that can ‘communicate’ quickly with the other
vertices in the graph.29 The closeness of a vertex is defined as
the reciprocal of the sum of the distance from the vertex of
interest to all of the others in the graph. The closeness values
for the HEPbps conserved basic amino acid sequence networks
were bivariate; vertices with a higher closeness value residing in
the core of the graph (ESI,† Fig. S1). After the isolated vertices
were removed from the graphs, the number of communities
found decreased. The majority of the communities had a large
population and high average degree; for example, HEPbp BX
HBS graph had 412 communities, HEPbp BXP HBS network 585
communities and HEPbp BXPS HBS graph 174 communities.
Further information can be found in ESI,† Table S2 and
Table 1.
3.4 Amino acid types
Historically, investigations looking for heparin-binding
sequences within proteins have concentrated on amino acid
types, i.e., basic, hydrophobic, etc. For the initial survey of the
graphs we adopted the same approach. The sequence that each
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Table 1 Properties of the HBS networks constructed from 437 HEPbp
BX BXP BXS BXA BXPS BXPA BXAS
Whole network
No. of starting sequences 10 447 15 426 15 740 13 536 14 124 14 479 16 663
No. of vertices 8987 8439 10 905 9801 3281 4724 7500
No. of unique sequencesa 4652 6099 7281 6154 2743 3837 5798
No. of edges 121 007 39 002 82 277 81 265 4774 9771 24 852
Network density 3  103 1.10  103 1.38  103 1.69  103 8.87  104 8.76  104 8.84  104
Average degree 26.93 9.24 15.09 16.58 2.91 4.14 6.63
Clustering coeﬃcient – transitivity 0.491 0.443 0.453 0.464 0.498 0.451 0.436
No. of communities 566 1311 1288 897 821 931 1160
Closeness selected network core
No. of starting sequences 10 447 15 426 15 740 13 536 14 124 14 479 16 663
No. of vertices 8624 6740 9718 8875 1566 3100 5631
No. of unique sequencesa 4348 4606 6265 5347 1315 2473 4191
No. of edges 120 742 37 800 81 409 80 598 3513 8655 23 563
Network density 3.25  103 1.66  103 1.72  103 2.05  103 2.86  103 1.80  103 1.49  103
Average degree 28 11.22 16.75 18.16 4.49 5.58 8.37
Clustering coeﬃcient – transitivity 0.491 0.443 0.452 0.464 0.483 0.446 0.435
No. of communities 412 585 780 503 174 270 363
a Even though a vertex is identified by the parent protein and sequence when determining the number of unique sequences, only the peptide
sequences were considered.
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vertex represents was converted into its amino acid type. For
example, the sequence LLR was converted to XXB.
To find important sequences, the ratio of the degree cen-
trality, the number of vertices incident on a node – how many
sequences overcome the similarity cut-off to the number of
sequences, was considered (ESI,† Fig. S2). The majority of
sequences within the graphs have a low degree to number
ratio. This can be seen in ESI,† Fig. S2, in which the density plot
of the degree to the number ratio illustrates that there are two
populations. The population with the high degree to number
ratio comprise shorter sequences, containing 3 or 4 amino
acids. Sequences that contain special amino acids; C, G or P,
contain significant sequences which are much longer, i.e., in
the BXPS graph vertices belonging to the sequence
PSSSSPSSSPSSSSSBS have a high degree to number ratio. All
of these sequences can be found in ESI,† Table S3. The total
number of amino acid sequences found the various HEPbp
HBS networks expressed as their amino acid type can be found
in ESI,† Tables S7, S9, S11, S13, S15, S17 and S19.
3.5 Network centralities
The four centrality measures (eigenvector, degree, closeness
and betweenness) give diﬀerent, but related, insights into
important network properties. The most informative and gran-
ular measure is the eigenvector centrality, as this identifies
individual vertices that are connected to other important –
highly connected – vertices. In the case of the networks being
studied here, these are conserved sequences that are linked to
other important conserved sequences. Table 2 contains the
vertices that are in the top 1% by eigenvector centrality. These
important vertices comprise a small fraction of the total num-
ber of vertices that compose the graphs; {B,X} 86 of 8987,
{B,X,A} 89 of 6154, {B,X,P} 67 of 6099, {B,X,S} 97 of 7281,
{B,X,P,A} 30 of 9771, {B,X,P,S} 16 of 4774 and {B,X,A,S} 56 of
5798. The sequences highlighted in the analysis of the {B,X}
and {B,X,A} networks contained the amino acids L and R, with
the sequence LLR (XXB) appear 33 and 22 times in the {B,X}
and {B,X,A} graphs, respectively (Table 2). The important ver-
tices found in the {B,X,P} and {B,X,P,A} networks were asso-
ciated with the conserved amino acid sequence SYR (SXB),
while the {B,X,S}/{B,X,P,S} networks had significant vertices
containing the conserved amino acid sequence G?KG (S?BS),
present as: A (X, prevalent in the {B,X,P,S} network); T, K, L, F, P
(P, B, X, X, S, prevalent in the {B,X,S} network), and M (X).
Finally, the sequence YCR (XSB) was important in the {B,X,S,A}
network. Important sequences and the proteins that contain
them as determined by the degree, closeness and betweenness
centralities can be found in ESI,† Tables S4, S5 and S6,
respectively.
3.6 Communities
Another means of describing a graph is by determining the
number of communities/clusters that the graph contains. The
number of communities found in the networks is a measure of
the diversity of the sequences the graphs represent. The
method used here to determine the number of communities
was based on a random walk, the number of steps taken was
chosen by analysing the {B,X} network and determining the
modularity of the clustered networks. The number of steps that
produced the lowest modularity, before the modularity of the
analyses converged, was 7.
The networks formed of sequences that contain 4 diﬀerent
types of amino acid ({B,X,P,S}, {B,X,P,A}, and {B,X,A,S}) contain
the fewest communities, BXPS, 174; BXPA, 270 and BXAS, 363.
The most diverse network is formed by sequences that comprise
basic, hydrophobic and special amino acids (BXS). This has 780
communities. The conserved sequences for the most significant
communities can be found in Table 3. The gauge of significance
used was size. The vertices that form the communities represent
amino acid sequences that are very similar to each other, there-
fore, the greater the number of vertices that comprise a com-
munity, the more important is the conserved sequence.
The significance cut-oﬀ was the 95th percentile. The distribu-
tion of community sizes had a positively skewed distribution, the
number of significant communities found for the diﬀerent
graphs were, {B,X}, 21 of 421; {B,X,A}, 25 of 203; {B,X,P}, 30 of
585; {B,X,S}, 39 of 280; {B,X,P,S}, 9 of 174; {B,X,P,A}, 14 of 270
and {B,X,A,S}, 18 of 363. It is interesting to note that the core of
the conserved sequences from the most significant communities
are relatively short, three or four amino acids long, as seen in the
eigenvector analyses, corresponding to small discrete areas on a
protein surface. Tables can be found in ESI† that contain the
conserved sequences, amino acid entropy and amino acid fre-
quency for the significant communities found in networks
formed from the {B,X}, {B,X,A}, {B,X,P}, {B,X,S}, {B,X,P,A},
{B,X,P,S} and {B,X,A,S} amino acid sets, ESI,† Tables S8, S10,
S12, S14, S16, S18 and S20, respectively.
3.7 Conserved sequences in proteins
In order to validate this approach for identifying HBSs within
HEPbps, the sequences extracted for a small set of proteins
were compared against their experimentally determined HBSs.
Molecular schematics and tables of the predicted HBSs can be
found in ESI† (Fig. S3–S5 and Tables S21–S26). This approach
has previously been used to identify HS/heparin binding
sequences in H5N1 haemagglutinin (influenza A virus A/
Cygnus olor/Italy/742/2006).40
Fibroblast growth factors (FGFs) are a well-studied family of
HEPbps. They are a group of 21 proteins that bind to HSPGs
and FGF receptors (FGFRs) containing membrane-bound recep-
tor tyrosine kinase. The HS binding of the family has been
investigated using a mass spectroscopy ‘‘Protect and Label’’
strategy.41 The approach has been used to determine the HBS
for FGF-1, -2, -3, -4, -6, -7, -9, -10, -17, -18 and -20.41–43 The
principal example shown in the text is for FGF-1, colloquially
termed acidic FGF. The network analysis method described here
identifies sequences within this protein that are highly similar
to sequences found in other proteins known to bind heparin/
HS, see Fig. 1. The molecular representation of FGF-1 (Fig. 1),
shows these conserved basic amino acid sequences creating an
extended region around the protein (Fig. 1, lower network).
Highlighted in this network are the amino acids (grey vertices)
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Table 2 Influential sequences within the HEPbp basic amino acid containing sequence networks. The table contains the significant sequences as
determined by the eigenvector centrality, the number of times that particular sequence appears in the network and the proteins that contain it. The
vertices were considered significant if they were in the 99th percentile
BX BXA BXP BXS BXPA BXPS BXAS
Seq. n Prot. Seq. n Prot. Seq. n Prot. Seq. n Prot. Seq. n Prot. Seq. n Prot. Seq. n Prot.
LLR 33 5NTD LLR 22 AACT SYR 7 A1BG GPKG 9 A1BG SYR 5 FA12 GAKG 5 C1QA YCR 4 FGF9
LLRL 5 A1BG LRL 15 ABCBB SYRT 1 FA12 GKG 8 A2MG LSYR 1 FBLN7 GTKG 4 CO1A1 LYCR 3 FGF16
LMLR 3 AACT LRLV 3 ABP1 LSYR 1 FBLN7 GLKG 7 APLP1 SSYR 1 FBN1 AGAKG 2 CO1A2 FGF20
LRL 3 ABP1 LMLR 3 APLP1 SSYR 1 FBN1 GAKG 7 APOB ESYR 1 FBN2 KGAKG 2 CO5A1 HGF
HLLR 2 APOB LLRL 3 APOB KSYR 1 FBN2 GPRG 7 ATS3 SEYR 1 HGF GKG 2 CO5A3 PLMN
ALLR 2 ATRN LRAL 3 ATS8 SYNR 1 HGF PGPKG 7 C1QA SYNR 1 HMGB1 GKKG 1 CO8A TPA
KLLR 2 CBPD HLLR 2 BACE1 ASYR 1 IBP5 PKG 5 CAC1S ASYR 1 ITA1 TGAKG 1 COBA1 UROK
RLLR 2 CHRD LLDR 2 CAC1S QSYR 1 ITA1 RGPKG 3 CCL28 QSYR 1 LAMA5 GNKG 1 COBA2
LLRI 2 CO3 LREL 2 CBPD SWYR 1 LAMA5 GRG 3 CO1A1 SWYR 1 LTBP1 GAKA 1 CODA1
LALR 2 CO4A ALLR 2 CHRD ISYR 1 LTBP1 GPK 2 CO1A2 ISYR 1 PLMN PGAKG 1 CO1
LLLR 2 CO9 LDLR 2 CO3 SAYR 1 NRP1 AGPKG 2 CO3 SAYR 1 TIMP3 GLKG 1 HMGB1
LLRH 1 COBA2 LLRE 2 CO4A PLMN GMKG 2 CO3A1 TPA GAKS 1 LAMA4
FLLR 1 COCA1 LRVL 2 CO5 TIMP3 VGPKG 2 CO5A1 TSP4 GFKG 1 MBL2
LRLR 1 COIA1 LRLL 2 CO6A3 TPA GPKA 2 CO5A3 PGBM
LKLR 1 COJA1 FLLR 1 COBA2 TSP4 LPKG 1 CO6A3 Q9HCS8
LLRK 1 COMP LERL 1 COMT GKKG 1 CO9A1 TSP1
LLRV 1 COMT LELR 1 CXCL6 KPKG 1 COBA1
LLRF 1 CO1 LRLR 1 CYR61 PGAKG 1 COBA2
LLRR 1 ENOA LLRK 1 DCC GGKG 1 COCA1
LLRY 1 ENPP3 LRV 1 ECM2 GARG 1 CODA1
LHLR 1 FGFP3 LKRL 1 ERBB2 GVKG 1 COEA1
LLYR 1 FGFR4 LRFL 1 FA11 KGAKG 1 COIA1
VLLR 1 FSTL1 LRIL 1 FBN1 GHKG 1 COJA1
LLFR 1 HBEGF LARL 1 FGF4 GPKGR 1 COLQ
LLHR 1 HFE LRLY 1 FGF18 GIKG 1 CO1
YLLR 1 INSR KLLR 1 FGFR4 LGPKG 1 COPA1
ITIH3 RLLR 1 FSTL1 MGPKG 1 CRLD2
LAMA1 LRLA 1 HFE KGPKG 1 ERBB2
LAMA2 DLLR 1 ITIH3 GPKGL 1 FINC
LAMA3 LLRF 1 KALM GPKH 1 HMGB1
LAMA5 LLRR 1 LAMA1 GPKC 1 IBP4
LGR4 LRKL 1 LAMA2 GPPKG 1 LAMA2
LIFR LHLR 1 LAMA3 GFKG 1 LAMA5
LIPC LRRL 1 LAMA5 VPKG 1 MBL2
LPHN2 FLRL 1 LGR4 MMP9
MET LLYR 1 LIFR PAIRB
MOT8 LALR 1 LPHN2 PCSK5
MRP6 LYRL 1 MET PEBP1
V2 LLHR 1 MOT8 PGBM
NOGG YLLR 1 MRP6 POSTN
PCOC2 LLRD 1 V2 S12A9
PCSK5 NOGG TSP1
PERM PCOC2 TSP2
PGBM PCSK5 XDH
PGS1 PGBM
PLGF PGS1
PRG2 PIGR
S12A9 PLGF
S22AI PRDX4
SCN5A PRELP
SEM5B PRG2
SLIT1 PSN1
SLIT2 RL29
TEN1 S12A9
TE S20A2
TENX S22AI
THYG SCN5A
TRFE SLIT1
TRFL SLIT2
TSP3 TE
TSP4 TENX
VGFR1 TGM2
WNT1 THYG
XDH TRFL
ZPI TSP2
TSP3
VGFR1
XDH
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Table 3 Conserved aligned sequences from the communities found in the HEPbp HBS networks. The table contains the conserved aligned sequences
for the most significant communities. The measure of significance used was the size of the communities. A community was considered significant if it
was in the 95th percentile
BX BXP BXA BXS BXPS BXPA BXAS
Com1 ----AAK--- Com1 --RRR-- Com1 --FRY Com1 --VVK--- Com5 -G-PGPKG--- Com2 -RDS- Com1 ---GRR--
----XXB--- --BBB-- --XBX --XXB--- -S-SSSBS--- -BAP- ---SBB--
Com3 ---LLR---- Com3 --FRI Com3 ----KKV--- Com2 ----KLL----- Com13 --LGR- Com7 ---RS--- Com2 ---KPC-
---XXB---- --XBX ----BBX--- ----BXX----- --XSB- ---BP--- ---BSS-
Com4 -----VKK Com4 ---KKL--- Com7 ----LLR--- Com3 ---LR---- Com16 ---GKKG Com8 KNEE- Com3 ----LLR--
-----XBB ---BBX--- ----XXB--- ---XB---- ---SBBS BPAA- ----XXB--
Com5 ----RLL--- Com6 ---AKK-- Com8 --ARR-- Com4 ------KVV-- Com17 KVL-- Com9 --SLR-- Com4 ----LKK-
----BXX--- ---XBB-- --XBB-- ------BXX-- BXX-- --PXB-- ----XBB-
Com6 ----RA----- Com11 --RAA-- Com9 ---LKK--- Com13 --KII-- Com18 ---KLK- Com10 --RVS-- Com5 --KKI--
----BX----- --BXX-- ---XBB--- --BXX-- ---BXB- --BXP-- --BBX--
Com8 -FFH-- Com12 --VLK Com12 ----KKK--- Com14 -HPP-- Com27 -LLRL- Com11 --SKK Com7 ----VLK-
-XXB-- --XXB ----BBB--- -BSS-- -XXBX- --PBB ----XXB-
Com10 --LHL-- Com17 --LVK-- Com13 ---RRR--- Com15 -PPR---- Com30 CIFK Com13 --AVK- Com8 --IR---
--XBX-- --XXB-- ---BBB--- -SSB---- SXXB --XXB- --XB---
Com11 ------K--LL-- Com21 ---LR--- Com16 ---RLL---- Com16 --RVR-- Com49 -GRS- Com21 KKKS- Com19 --GGH----
------B--XX-- ---XB--- ---BXX---- --BXB-- -SBP- BBBP- --SSB----
Com13 --KKKK--- Com25 --RLL---- Com18 ----HFL- Com20 ---RRIP-- Com60 GRCC- Com26 SKL-- Com21 ------KKK--
--BBBB--- --BXX---- ----BXX- ---BBXS-- SBSS- PBX-- ------BBB--
Com18 ---LLK-- Com32 --QQR- Com20 --HAA-- Com21 -CVR-- Com30 KAL-- Com22 -RAA--
---XXB-- --PPB- --BXX-- -SXB-- BXX-- -BXX--
Com25 ----HHL-- Com33 -LHV-- Com25 --HLA-- Com22 --RAA--- Com37 SRR-- Com27 --GGK-
----BBX-- -XBX-- --BXX-- --BXX--- PBB-- --SSB-
Com26 -KKR-- Com34 -QRVV-- Com29 --EIH- Com24 --LAH- Com43 --KKL Com29 --RLP--
-BBB-- -PBXX-- --AXB- --XXB- --BBX --BXS--
Com29 --KVV-- Com37 ---KKK-- Com32 --LH--F Com25 ----AAR- Com47 ---RL-- Com45 --LLH-
--BXX-- ---BBB-- --XB--X ----XXB- ---BX-- --XXB-
Com32 ---VVR--- Com39 --KKF Com42 --KEI Com26 ------L--KK----- Com49 -NKK- Com46 --DGK-
---XXB--- --BBX --BAX ------X--BB----- -PBB- --ASB-
Com35 ----LLH-- Com43 --RSS-- Com48 -LHD-- Com31 --RRRR- Com48 --VVR--
----XXB-- --BPP-- -XBA-- --BBBB- --XXB--
Com37 -IIR--- Com46 --KKK-- Com49 --RAA-- Com32 -CKGC Com49 ---RLL--
-XXB--- --BBB-- --BXX-- -SBSS ---BXX--
Com40 --HAA--- Com48 --ASK Com57 -EER-- Com34 ---RGG-- Com70 --PRA--
--BXX--- --XPB -AAB-- ---BSS-- --SBX--
Com42 IHH-- Com58 -AAR- Com58 -FFK-- Com35 --KKKA--- Com80 LHLL-
XBB-- -XXB- -XXB-- --BBBX--- XBXX-
Com74 --KII-- Com64 --HHL Com59 --HVL-- Com38 --GHH--
--BXX-- --BBX --BXX-- --SBB--
Com98 -HLA-- Com66 -KSQ- Com64 --RRV-- Com43 --HLG--
-BXX-- -BPP- --BBX-- --BXS--
Com69 -KSS-- Com75 --LLH- Com46 ----GPPGPKG---
-BPP-- --XXB- ----SSSSSBS---
Com80 --SLH-- Com83 -FHI- Com47 --LLR--
--PXB-- -XBX- --XXB--
Com83 -VVKS Com101 -IHL-- Com52 --GRC---
-XXBP -XBX-- --SBS---
Com98 --KIT-- Com120 -H--VV Com54 --LLH---
--BXP-- -B--XX --XXB---
Com99 --RNT- Com326 -AAH- Com56 --GLH-
--BPP- -XXB- --SXB-
Com100 -KVT-- Com60 ---RLL----
-BXP-- ---BXX----
Com113 -IYKT- Com62 --LHL-
-XXBP- --XBX-
Com120 --VRT- Com63 --CRK--
--XBP- --SBB--
Com125 -TARK Com69 --VVR-
-PXBB --XXB-
Com161 --KVN- Com76 -----GPK---G----
--BXP- -----SSB---S----
Com96 --KIG-
--BXS-
Com97 --RHGY
--BBSX
Com101 -IKK-
-XBB-
Com110 -RGLPG---
-BSXSS---
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that are within 0.8 nm of the conserved amino acids and that
arise in at least two of the seven sets: {B,X}; {B,X,A}; {B,X,P};
{B,X,S}; {B,X,P,A}; {B,X,P,S}; and {B,X,A,S}.
The approximate length of the heparin/HS disaccharide is 0.8
nm,7 and therefore a longer chainmay lie across multiple connected
vertices. These connected vertices would then form an extended
heparin/HS binding domain. The ‘Protect and Label’ mass spectro-
metry performed on FGF-1 identified four heparin binding regions:
KKPKLLY (amino acids (aa) 24–30); IKSTETGQYL (aa71–80); ISK-
KHAEKNWF (aa113–123); and VGLKKNGSCKRGPRTHYGQAILFLPL
(aa124–150).42 The analysis described above identified amino acid
sequences within each of the previously identified regions in FGF-1
that interact with HS/heparin (Fig. 1).
The network analysis was also validated against the FGF-2,
FGF-7, FGF-9 and FGF-18 proteins. The conserved basic amino
acid sequences of these proteins are shown in Fig. 2 with the
‘protect and label’ mass spectroscopy hits (Table 4).41,42 Further-
more, validation against FGF-3, -4, -6, -10, -17 and -20 are in ESI.†
The above analysis indicates that the conserved amino acid
containing sequences that are found in HEPbps form a significant
part of the heparin binding regions of a protein. Further illustra-
tions of this fact include, hepatoma-derived growth factor (HDGF),
lymphotactin (chemokine (C motif) ligand (XCL1)) and interleukin-
10 (IL10). Solution NMR analysis of hepatoma-derived growth
factor indicated that it had a primary heparin binding site and
then possibly a minor binding site at the N-terminal of the protein.
The primary HBS consists of K 19, 61, 72, 78 and 80, as well as R 79.
The secondary site, which resides in the flexible N-terminus of the
molecule is formed of R2 and R6, and K8 and K11.44 The similarity
analysis found all the members of the proposed principal binding
site apart from K19. In fact, this amino acid was found by the
analysis, but it only appeared once, in the BX group of amino acids.
Of the minor binding site, only K11 was found to be significantly
conserved, while K8 appeared once in the BXA amino acid group
analysis. The network representation of HDGFs HBS highlights
how the conserved basic amino acid containing sequences could
come together to form the principal HBS, with the conserved
sequence 28ARI30 linking the primary and secondary HBSs together
(ESI,† Fig. S3).
Another example is lymphotactin, a small cytokine. Petersen
et al.45 used backbone 1H and 15N chemical shift perturbations to
identify the following amino acids as interacting with heparin, R39,
R44, K46, K63, R64, K67, R78, R86, K87, and R91. Further use of
site-directed mutagenesis identified R44 and R64 as the high
aﬃnity residues. All but three of these amino acids were identified
by the similarity method employed in this manuscript, and these
were K63, R64 and R70. The method was able to identify one of the
high aﬃnity binding residues and 70 percent of the total interact-
ing residues (ESI,† Fig. S4).
The final example shown is interleukin-10 (IL-10), which is a
cytokine involved in inflammation. It inhibits the production of
inflammatory cytokines.46 It has been determined by NMR that
IL-10 interacts with heparin via a binding site that comprises
resides in helix D and the adjacent DE loop.46 The residues
involved in the interaction are R120, R121, R124, R125, K135
and K137. The analyses shown in this manuscript identify all of
these residues except K135. In particular, the analyses identify a
domain comprising 8 basic amino acids, R42, R120, R122,
R124, R125, R128, R127, H32 and H127 (ESI,† Fig. S5).
It should be noted that in the examples shown here, the FGFs,
HDGF, XCL1 and IL-10, that the proteins contain conserved basic
amino acid containing sequences that correspond to the experi-
mentally determinedHBSs, but there are also other conserved basic
amino acid containing sequences that are found in these bona fide
HEPbps.When heparin/HS binding studies are performed on these
proteins the system may be in solution, for the case of NMR and
MS studies, but this is still not the natural state of the system. Most
of the proteins considered in this study are extracellular, either
membrane bound or secreted in to the ECM. This environment is
extremely crowded, being composed of many proteins and carbo-
hydrates, of which proteoglycans are an important. These addi-
tional conserved basic amino acid containing sequences found in
the HEPbps may be related to the interaction of the HEPbp and its
surrounds, for e.g., storage of the HEPbps in the ECM or control of
HEPbps diﬀusion through the ECM, suggesting that there are
primary and secondary HBS within HEPbps. In addition to other
functions such stabilising the structure of the protein. The primary
sites are related to a specific biological activity, i.e., the HBS related
to a protein cell signal activity, while the secondary sites assist in
the control and movement of the proteins though its environment.
It is conceivable that a very large number of proteins interact with
heparin/HS but, obviously, not all of them require heparin/HS for
their biological activity.
3.8 Human proteome
The result of searching the human proteome for the conserved
basic amino acid containing sequences found in the 437
HEPbp is interesting. From this analysis, two main pieces of
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Table 3 (continued )
BX BXP BXA BXS BXPS BXPA BXAS
Com114 --GKK----
--SBB----
Com122 --KGP--
--BSS--
Com132 --FHL--
--XBX--
Com153 -RLA--
-BXX--
Com179 --PC-K
--SS-B
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information can be ascertained. The first, is the number of
times a conserved basic amino acid containing sequence arose
in the members of the human proteome. Unlike the earlier
analysis performed, where discrete sequences were found in a
set of HEPbp, this analysis searched for the sequences found in
the earlier analysis in the entire human proteome. As a
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Fig. 1 Conserved basic amino acid containing sequences found in FGF-1. The table shows the sequences found for the diﬀerent amino acid
combinations. As a further selection criterion, an amino acid was only considered to be significant if it arose at least twice in the diﬀerent amino acid
groups, e.g., R50 appears in the BXA, BXPS and BXAS selections. The conserved amino acids are illustrated on the molecular structure of FGF-1 (1RG8).47
This structure was also represented as a network, the vertices of the network are the aC positions. In the bottom network conserved basic amino acid
containing residues are shown, along with any amino acid that is less than 0.8 nm away – the approximate length of a HS/heparin disaccharide. This
reductionist view illustrates how the small basic amino acid containing sequences in unison can form an extended heparin-binding domain. The
previously identified HBSs of FGF-1 can be found in Table 4.
10 | Mol. BioSyst., 2017, 00, 114 This journal is c The Royal Society of Chemistry 2017
Paper Molecular BioSystems
consequence of this, overlapping sequences will be found in
proteins. For example, the sequence ARLLAR could have the
sequences ARL, RLL, LLAR and LAR as hits. The second piece of
information is the frequency with which a specific basic amino
acid containing sequence appears in the human proteome.
The median values for the number of diﬀerent basic amino
acid containing sequence types found per protein in the human
proteome were: 42 BX, 61 BXA, 69 BXP, 64 BXS, 67 BXPA, 32
BXPS and 70 BXAS. With the 99th percentile values being: 213
BX, 333 BXA, 398 BXP, 316 BXS, 311 BXPA, 156 BXPS and 347
BXAS. The unique list, a combination of all proteins with more
than or equal to the 99th percentile for the diﬀerent amino acid
combinations, contained 329 proteins, which can be found in
ESI,† Table S27. Of these 329 proteins, 17 are found in the 437
HEPbps that were originally analysed, they are: APOB, apolipo-
protein B-100; ATS9, a disintegrin and metalloproteinase with
thrombospondin motifs 9; CAC1S, voltage-dependent L-type
calcium channel subunit alpha-1S; CO6A3, collagen alpha-3
(VI) chain; COCA1, collagen alpha-1 (XII) chain; FBN1, fibrillin-
1; LAMA1, laminin subunit alpha-1; LAMA2, laminin subunit
alpha-2; LAMA3, laminin subunit alpha-3; LAMA5, laminin
subunit alpha-3; NAV2, neuron navigator 2; PGBM, basement
membrane-specific heparan sulfate proteoglycan core protein;
STAB2, stabilin-2; TEN1, teneurin-1; TENX, tenascin-X; THYG,
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Fig. 2 Conserved basic amino acid containing sequences found in members of the FGF family. In these networks conserved basic amino acid containing
residues are shown along with any amino acid that is less than 0.8 nm away, the approximate length of a HS/heparin disaccharide. The previously
identified HBSs, FGF-2, -7, -9 and -18 can be found in Table 4. The PDB files used to produce the networks were, FGF-2, 1BFF;53 FGF-7, 1QQK;54 FGF-9,
1IHK55 and FGF-18, 4CJM.56
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thyroglobulin and VWF, von Willebrand factor. Many of these
are integral components of the extracellular matrix. For exam-
ple, STAB2 is a large transmembrane receptor that acts as a
scavenger for heparin and other GAGs, which may assist in
maintaining tissue integrity by supporting extracellular matrix
turnover. If the 437 bona fide HEPbp are considered as a whole,
they have a higher median number of basic amino acid contain-
ing sequences than the whole human proteome, apart from
sequences comprised of BXPA amino acids and the 99th
percentiles values are all higher: median – 45 BX, 66 BXA, 75
BXP, 74 BXS, 58 BXPA, 34 BXPS and 77 BXAS and 99th
percentile – 240 BX, 352 BXA, 429 BXP, 445 BXS, 327 BXPA,
191 BXPS and 462 BXAS. If one makes the selection criteria a
little milder, the 95th percentile, then that pushes the number
of proteins up to 1518, which is approaching B14% of the
human proteome. This suggests that many proteins found in
humans possibly interact with HS/heparin. This is not an
absolute measure of heparin binding, as the analysis finds
overlapping sequences. It does though provide a measure of the
propensity of a protein to interact with heparin/HS.
These data support the conjecture that if many proteins can
bind to these polyanions, then the mechanism of control may not
lie at the level of the protein, but in the sequences found in the
polysaccharide chains. This would go some way to explaining why
so much energy has been committed to produce the many HS/
heparin biosynthetic enzymes (4 enzymes for chain initiation, 2
enzymes for chain extension and 16 enzymes for chain modifica-
tion – a total of 22 enzymes for a single polysaccharide chain).
The significant conserved basic amino acid containing
sequences all appear more than 2000 times (99th percentile,
2857 BX, 3271 BXP, 2826 BXS, 3083 BXA, 3816 BXPA, 3818 BXPS
and 3361 BXAS) in the human proteome. The median value was
considerably lower than that (median – 42 BX, 69 BXP, 64 BXS,
61 BXA, 67 BXPA, 32 BXPS and 70 BXAS). All the significant
sequences were tri-peptides. The sequences on the whole con-
tained either arginine or lysine, with only two histidine-
containing sequences found in the significant populations,
HLL and LLH. The unique list, a combination of all sequences
with more than or equal to the 99th percentile for the different
amino acid combinations, contained 98 sequences, as follows;
ARR, KLA, LAK, LLR, LKL, KAA, RLA, KLK, RRA, ARL, KKL, RAA,
RVL, KRK, LRR, ALK, LRA, RAL, RKL, KVL, ALR, LRK, LKA, RLL,
LKK, KAL, KLL, RLR, AAR, RKK, ARA, VLK, LLK, KKK, RRL, LRL,
LAR, LKR, KRL, VLR, HLL, LRV, RRR, EKK, EER, ELK, KEE,
KLE, KEL, EKE, LEK, EEK, ELR, LKE, ERL, REE, LER, LRE, EKL,
RLE, KEK, LKD, REL, RSS, LQR, LRS, SSR, RLS, LSR, SRL, KSL,
SLR, LKS, RSL, LQK, LSK, SLK, SRS, RLG, GRR, LRG, GLR, GRG,
RLP, RLK, PRP, LRP, RGL, PRL, LPR, GRL, PPR, KLR, GKL, LVK,
LLH, LGK and LGR.
4. Conclusions
These analyses indicate that basic regions, and therefore
heparin binding sites within HEPbps, are highly variable,
containing only small conserved motifs at the heart of the
HBS. It is likely that many of these small basic sequences work
in unison via multiple heparin binding sites on a protein
surface. This implies that there is agility and leeway in the
composition of the complementary protein binding surface,
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Table 4 Heparin binding regions of the FGF family previously identified by the ‘protect and label’ mass spectrometry method.41 Amino acids that are
highlighted in bold were found in the similarity analysis, appearing at least twice in the diﬀerent amino acid groups
Amino acid sequence
Start End
Ref.aa aa
FGF-1 KKPKLLY 24 30 Xu et al. protect and label ms42
IKSTETGQYL 71 80
ISKKHAEKNWF 113 123
VGLKKNGSCKRGPRTHYGQAILFLPL 124 150
FGF-2 KDPKRLYCKNGGFF 160 173 Ori et al. protect and label ms41
LAMKEDGRLL 216 225
VALKRTGQY 258 266
KLGSKTGPGQKAIL 267 280
FGF-7 YLRIDKRGKVKGTQEMKNNY 76 95 Xu et al. protect and label ms42
LAMNKEGKLY 119 128
ASAKWTHNGGEMF 152 164
VALNQKGIPVRGKKTKKEQKTAHF 165 188
FGF-9 HLEIFPNGTIQGTRKDHSRF 73 92 Xu et al. protect and label ms42
KHVDTGRRY 154 175
VALNKDGTPREGTRTKRHQKF 164 184
THFLPRPVDPDKVPELY 185 201
FGF-18 RIHVENQTRARDDVSRKQL 34 52 Xu et al. protect and label ms42
GRRISARGEDGDKY 70 83
GSQVRIKGKETEFYL 94 108
CMNRKGKLVGKPDGTSKECVF 109 129
TKKGRPRKGPKTRENQQDVHFM 154 175
MKRYPKGQPELQKPF 175 189
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comparable to the latitude observed in binding sequences of
HS. These data preclude the notion of there being a single,
universal HBS in the family of HEPbps, since many amino acid
sequence combinations are able to fulfil the same role.
Considering basic amino acid sequences found within
HEPbps is a first step to understanding the biochemistry of
these interactions. There are other facets to the interaction
between heparin/HS and their binding proteins that are likely
to have influence, including post-translational modifications,
GAG heterogeneity, cationic association and the possibility
that, in some cases, HEPbps may be active independent of
the presence of heparin/HS.
Diﬀering post-translation modification has been shown to
regulate the interaction between the protein and carbohydrate.
For example, glycosylation of the protein ligand in FGFR-1 alters
the aﬃnity of the interaction.48 Not all GAGs are equivalent
however. Both heparin and HS are heterogeneous polysacchar-
ides with their disaccharide sequences dependent on the organ
from which they originate.49 As polyanionic polysaccharides,
both heparin and HS are associated with diﬀerent cations that
modify their conformation.50 For example, it has been shown
that a biologically inactive carbohydrate is activated by the
addition of the appropriate cation.51 In some cases (e.g., FGF-1
and -2) heparin/HS dependant signalling pathways have been
stimulated by non-GAG materials, including sulfated plant poly-
saccharides. For these FGFs, such proxy-GAG carbohydrates only
need to either thermally stabilise or induce the correct confor-
mational change in the HEPbp for signalling to be maintained.52
It is diﬃcult to rationalise an explicit control mechanism for
systems regulated by protein and HS/heparin interactions. The
innate elasticity of the HBSs within HEPbps, coupled to the
heterogeneity found in heparin and HS precludes this. Instead
of focusing on the interaction between a single protein and HS/
heparin to understand biological processes, these analyses may
indicate that a holistic view, taken over all the molecular
interactions may be more appropriate. Specifically, they indi-
cate that HEPbps interact with HS/heparin in a multitude of
ways, and in complex networks, which enables them both to
perform many tasks and for these capabilities to be both
interdependent in complex ways but, also backed-up by robust
systems. The network analyses above utilise a multi-
dimensional technique to interrogate this multi-faceted
interactome.
These multi-dimensional network analyses of HEPbp
sequences have identified HBSs on a family-wide scale. They
have indicated that HBSs may be composed of multiple, small,
independent basic amino acid stretches that work in unison to
form the HBS regions. A single universal HBS is therefore
unlikely; rather many arrangements of amino acids may fulfil
the same task. These observations lead to two logical inferences:
that HEPbps possess an agility in their heparin/HS interactions;
and that there may be a higher degree of convergent evolution in
HBPs than previously thought. These analyses provide both an
insight and springboard into the HEPbp, heparin and HS inter-
actomes, as well as a validated technique for investigating
protein sequences at a phenotypic level.
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